Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Preferred Stock
Preferred Stock Series A
Preferred Stock
Preferred Stock Series A-1
Preferred Stock
Preferred Stock Series A-2
Preferred Stock
Preferred Stock Series B
Preferred Stock
Preferred Stock Series C
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2020     43,737,586 48,913,906 14,003,187 15,838,828 60,665,631 62,832,307        
Beginning balance at Dec. 31, 2020 $ 188,031   $ 1 $ 1 $ 0 $ 0 $ 1 $ 1 $ 266,464 $ (79,123)   $ 686
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Exercise of stock options (in shares)               2,637,441        
Exercise of stock options 1,267               1,267      
Stock based compensation expense 2,289               2,289      
Original issue discount on senior secured credit agreement 18,519               18,519      
Net loss (11,758)                 (11,758)    
Other comprehensive loss (686)                     (686)
Ending balance (in shares) at Mar. 31, 2021     43,737,586 48,913,906 14,003,187 15,838,828 60,665,631 65,469,748        
Ending balance at Mar. 31, 2021 $ 197,662   $ 1 $ 1 $ 0 $ 0 $ 1 $ 1 288,539 (90,881)   0
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2016-13                      
Beginning balance (in shares) at Dec. 31, 2020     43,737,586 48,913,906 14,003,187 15,838,828 60,665,631 62,832,307        
Beginning balance at Dec. 31, 2020 $ 188,031   $ 1 $ 1 $ 0 $ 0 $ 1 $ 1 266,464 (79,123)   686
Ending balance (in shares) at Dec. 31, 2021     0 0 0 0 0 323,347,806        
Ending balance at Dec. 31, 2021 $ 350,924 $ (399) $ 0 $ 0 $ 0 $ 0 $ 0 $ 33 543,070 (192,179) $ (399) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Exercise of stock options (in shares) 924,717             957,648        
Exercise of stock options $ (97)               (97)      
Vesting of RSU awards (in shares)               42,800        
Stock based compensation expense 11,579               11,579      
Net loss (50,026)                 (50,026)    
Ending balance (in shares) at Mar. 31, 2022     0 0 0 0 0 324,348,254        
Ending balance at Mar. 31, 2022 $ 311,981   $ 0 $ 0 $ 0 $ 0 $ 0 $ 33 $ 554,552 $ (242,604)   $ 0